Cargando…
Phylogeny-Informed Synthetic Biology Reveals Unprecedented Structural Novelty in Type V Glycopeptide Antibiotics
[Image: see text] The rise and dissemination of glycopeptide antibiotic (GPA)-resistant pathogens in healthcare settings fuel efforts to discover GPAs that can overcome resistance. Members of the type V subclass of GPAs can evade common GPA resistance mechanisms and offer promise as new drug leads....
Autores principales: | Xu, Min, Wang, Wenliang, Waglechner, Nicholas, Culp, Elizabeth J., Guitor, Allison K., Wright, Gerard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136965/ https://www.ncbi.nlm.nih.gov/pubmed/35647273 http://dx.doi.org/10.1021/acscentsci.1c01389 |
Ejemplares similares
-
GPAHex-A synthetic biology platform for Type IV–V glycopeptide antibiotic production and discovery
por: Xu, Min, et al.
Publicado: (2020) -
Opportunities for Synthetic Biology in Antibiotics:
Expanding Glycopeptide Chemical Diversity
por: Thaker, Maulik N., et al.
Publicado: (2012) -
Synthetic Biology
Facilitates Semisynthetic Development
of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus
por: Koteva, Kalinka, et al.
Publicado: (2023) -
Antibiotic resistance: it’s bad, but why isn’t it worse?
por: Waglechner, Nicholas, et al.
Publicado: (2017) -
Synthetic glycopeptides and glycoproteins with applications in biological research
por: Westerlind, Ulrika
Publicado: (2012)